CureLab Veterinary Launches Equity Crowdfunding Campaign on Netcapital to Revolutionize Medicine for Dogs, Cats, and Horses

CureLab Veterinary addresses a $207 billion global pet cancer market, and Elenavetâ„¢, the company’s lead drug, has successfully treated 10 out of 11 dogs with breast cancer; this is an…

CureLab Veterinary Launches Equity Crowdfunding Campaign on Wefunder to Revolutionize Medicine for Dogs, Cats, and Horses

CureLab Veterinary, an emerging animal health biotech company, has launched its equity crowdfunding campaign in partnership with WeFunder, the nation’s leading investment crowdfunding platform. Pets are integral family members for…

University of Camerino Signs Strategic Partnership with CureLab Veterinary to Revolutionize Cancer Treatment for Companion Animals | News

The university is also renewing its agreement with CureLab Oncology to support its phase II clinical trials BOSTON and CAMERINO, Italy, April 19, 2022 /PRNewswire-PRWeb/ — The University of Camerino…